These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28433476)

  • 1. Patient with multiple acyl-CoA dehydrogenation deficiency disease and FLAD1 mutations benefits from riboflavin therapy.
    Auranen M; Paetau A; Piirilä P; Pohju A; Salmi T; Lamminen A; Löfberg M; Mosegaard S; Olsen RK; Tyni T
    Neuromuscul Disord; 2017 Jun; 27(6):581-584. PubMed ID: 28433476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavin adenine dinucleotide synthase deficiency due to FLAD1 mutation presenting as multiple acyl-CoA dehydrogenation deficiency-like disease: A case report.
    Yamada K; Ito M; Kobayashi H; Hasegawa Y; Fukuda S; Yamaguchi S; Taketani T
    Brain Dev; 2019 Aug; 41(7):638-642. PubMed ID: 30982706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S; Tavian D; Moro L; Angelini C
    Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.
    Olsen RKJ; Koňaříková E; Giancaspero TA; Mosegaard S; Boczonadi V; Mataković L; Veauville-Merllié A; Terrile C; Schwarzmayr T; Haack TB; Auranen M; Leone P; Galluccio M; Imbard A; Gutierrez-Rios P; Palmfeldt J; Graf E; Vianey-Saban C; Oppenheim M; Schiff M; Pichard S; Rigal O; Pyle A; Chinnery PF; Konstantopoulou V; Möslinger D; Feichtinger RG; Talim B; Topaloglu H; Coskun T; Gucer S; Botta A; Pegoraro E; Malena A; Vergani L; Mazzà D; Zollino M; Ghezzi D; Acquaviva C; Tyni T; Boneh A; Meitinger T; Strom TM; Gregersen N; Mayr JA; Horvath R; Barile M; Prokisch H
    Am J Hum Genet; 2016 Jun; 98(6):1130-1145. PubMed ID: 27259049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant with early onset bilateral facial and bulbar weakness: Successful treatment of riboflavin in multiple acyl-CoA dehydrogenase deficiency caused by biallelic nonsense FLAD1 variants.
    Lee YJ; Kim SY; Kim MJ; Kim AR; Lee JM; Chae JH
    Neuromuscul Disord; 2021 Nov; 31(11):1194-1198. PubMed ID: 34454814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified by newborn screening.
    Muru K; Reinson K; Künnapas K; Lilleväli H; Nochi Z; Mosegaard S; Pajusalu S; Olsen RKJ; Õunap K
    Mol Genet Genomic Med; 2019 Sep; 7(9):e915. PubMed ID: 31392824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.
    Goh LL; Lee Y; Tan ES; Lim JSC; Lim CW; Dalan R
    BMC Med Genomics; 2018 Apr; 11(1):37. PubMed ID: 29615056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
    Mosegaard S; Bruun GH; Flyvbjerg KF; Bliksrud YT; Gregersen N; Dembic M; Annexstad E; Tangeraas T; Olsen RKJ; Andresen BS
    Mol Genet Metab; 2017 Dec; 122(4):182-188. PubMed ID: 29122468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-mortem detection of FLAD1 mutations in 2 Turkish siblings with hypotonia in early infancy.
    Yıldız Y; Olsen RKJ; Sivri HS; Akçören Z; Nygaard HH; Tokatlı A
    Neuromuscul Disord; 2018 Sep; 28(9):787-790. PubMed ID: 30061063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple acyl-CoA dehydrogenation deficiency as decreased acyl-carnitine profile in serum.
    Wen B; Li D; Li W; Zhao Y; Yan C
    Neurol Sci; 2015 Jun; 36(6):853-9. PubMed ID: 25827849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system and muscle involvement in an adolescent patient with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Ishii K; Komaki H; Ohkuma A; Nishino I; Nonaka I; Sasaki M
    Brain Dev; 2010 Sep; 32(8):669-72. PubMed ID: 19783111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
    Yıldız Y; Talim B; Haliloglu G; Topaloglu H; Akçören Z; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Pediatr Neurol; 2019 Oct; 99():69-75. PubMed ID: 31331668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Law LK; Tang NL; Hui J; Fung SL; Ruiter J; Wanders RJ; Fok TF; Lam CW
    Clin Chim Acta; 2009 Jun; 404(2):95-9. PubMed ID: 19265687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of late-onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency (MADD) with a novel mutation in ETFDH gene.
    Zhuo Z; Jin P; Li F; Li H; Chen X; Wang H
    J Neurol Sci; 2015; 353(1-2):84-6. PubMed ID: 25913573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation.
    Wen B; Li D; Shan J; Liu S; Li W; Zhao Y; Lin P; Zheng J; Li D; Gong Y; Yan C
    Mol Genet Metab; 2013 Jun; 109(2):154-60. PubMed ID: 23628458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Truncating FLAD1 Variant, Causing Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) in an 8-Year-Old Boy.
    Ryder B; Tolomeo M; Nochi Z; Colella M; Barile M; Olsen RK; Inbar-Feigenberg M
    JIMD Rep; 2019; 45():37-44. PubMed ID: 30311138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset multiple acyl CoA dehydrogenation deficiency associated with an abnormal isoenzyme pattern of serum lactate dehydrogenase.
    Sugai F; Baba K; Toyooka K; Liang WC; Nishino I; Yamadera M; Sumi H; Fujimura H; Nishikawa Y
    Neuromuscul Disord; 2012 Feb; 22(2):159-61. PubMed ID: 21907580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study.
    Wen B; Tang S; Lv X; Li D; Xu J; Olsen RKJ; Zhao Y; Li W; Wang T; Shao K; Zhao D; Yan C
    Hum Mol Genet; 2022 Mar; 31(7):1115-1129. PubMed ID: 34718578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.
    Béhin A; Acquaviva-Bourdain C; Souvannanorath S; Streichenberger N; Attarian S; Bassez G; Brivet M; Fouilhoux A; Labarre-Villa A; Laquerrière A; Pérard L; Kaminsky P; Pouget J; Rigal O; Vanhulle C; Eymard B; Vianey-Saban C; Laforêt P
    Rev Neurol (Paris); 2016 Mar; 172(3):231-41. PubMed ID: 27038534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Chen M; Peng J; Wei W; Wang R; Xu H; Liu H
    Int J Neurosci; 2018 Mar; 128(3):291-294. PubMed ID: 28914566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.